Gross Revenue of US$49.23 Million and Cash Cost of US$1,288/Oz VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its financial results for the three months ended December 31, 2025 (“Q2 FY 2026”). All amounts are in United States dollars unless otherwise indicated (refer to www.sedar.com for full financial results). President and CEO Cathy Zhai commented, “In Q2 FY 2026, gold production and sales at the Selinsing Gold Mine in Malaysia, together with favourable gold prices, contributed to strong cash flow and enhanced the Company’s financial position. During the quarter, cash reserves increased by $19.81 million to $82.65 million, providing robust liquidity to support future growth initiatives. Exploration drilling at...

Zug, 02 March 2026 – Multitude AG, a listed European FinTech company, offering digital lending and online banking services to consumers, small and medium-sized enterprises, and other FinTechs (WKN: A40VJN, ISIN: CH1398992755) (“Multitude”, “Company” or “Group”) warmly invites financial analysts, investors, and media to its FY2025 Preliminary Results Presentation webcast. The event will be held virtually on Thursday, 12 March 2026, at 10:00 am CET.  A link for registration to the webcast is available on the company website in the subsection financial calendar https://www.multitude.com/investors/financial-calendar. Contact:Multitude AG Grafenauweg 8  6300 Zug Switzerland Adam Hansson TönningHead of IR and TreasuryPhone: +46733583171ir@multitude.com About Multitude AG: Multitude is a listed European FinTech company, offering digital lending...

      Recently Completed Inaugural Kinetic ABS and Refinancing Activity Strengthens Uniti’s Balance Sheet at Attractive Cost of Capital       Signed Largest Customer Contract in Uniti’s History with Prominent Hyperscaler       Provides Full Year 2026 OutlookNet Loss of $305.7 Million for the Fourth Quarter and Net Income of $1,304.7 Million for the Full Year Consolidated Revenue and Adjusted EBITDA of $917.3 Million and $365.6 Million, Respectively, for the Fourth Quarter Consolidated Revenue and Adjusted EBITDA of $2,234.5 Million and $1,173.8 Million, Respectively, for the Full YearLITTLE ROCK, Ark., March 02, 2026 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti” or the “Company”) (Nasdaq: UNIT) today announced its results for the fourth quarter and full year 2025. Key highlights during the quarter on a pro forma basis included:Consolidated...

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC); net sales in 2025 were $15.8 million, reflecting the initial launch period ahead of the permanent J Code Permanent J Code for ZUSDURI became effective on January 1, 2026, streamlining reimbursement procedures and supporting broader patient access JELMYTO® achieved net product sales of $94 million in 2025, representing year-over-year underlying demand sales growth of 7% Announced refinancing of existing term loan with Pharmakon Advisors that provides additional non-dilutive capital at more favorable terms Conference call and webcast to be held today at 10:00 AM ETPRINCETON, N.J., March 02, 2026 (GLOBE NEWSWIRE) — UroGen Pharma Ltd....

25% Year-Over-Year Production Growth and Highest Annual Free Cash Flow Since 2021 Receipt of New Drilling Permits Supports Planned 2026 Drilling Program LONG BEACH, Calif., March 02, 2026 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) (CRC) today reported its financial and operating results for the fourth quarter and full-year 2025. The Company plans to host a conference call and webcast at 1 p.m. ET (10 a.m. PT) on Monday, March 2, 2026. Conference call details can be found within this release. Fourth Quarter HighlightsReported net income of $12 million, adjusted net income1 of $40 million and $251 million of adjusted EBITDAX1 Generated net cash provided by operating activities of $235 million and $115 million of free cash flow1 Delivered an average of 137 thousand barrels of oil equivalent per day5 (MBoe/d)...

Achieves or exceeds all previously announced full-year 2025 guidance metrics On track to complete proposed acquisition by Nexstar Media Group by the second half of 2026, subject to regulatory approvals and customary closing conditions MCLEAN, Va., March 02, 2026 (GLOBE NEWSWIRE) — TEGNA Inc. (NYSE: TGNA) today announced financial results for the fourth quarter and full-year 2025, ended December 31, 2025. FOURTH QUARTER FINANCIAL HIGHLIGHTS:All Year-Over-Year Comparisons Unless Otherwise Noted:Total company revenue was down 19% from the prior year at $706 million primarily due to lower political advertising revenue, consistent with cyclical even-to-odd year comparisons partially offset by growth in Advertising and Marketing Services (AMS) revenue.  Distribution revenue was slightly lower at $358 million due to subscriber declines,...

– Planned submission for U.S. Accelerated Approval of z-rostudirsen on track for Q2 2026; potential launch in Q1 2027 – – Positive topline results reported from Phase 1/2 DELIVER trial of z-rostudirsen in exon 51 skip amenable Duchenne muscular dystrophy (DMD); additional long-term data to be presented at MDA – – Completion of enrollment in registrational expansion cohort of Phase 1/2 ACHIEVE trial of z-basivarsen in myotonic dystrophy type 1 (DM1) expected in Q2 2026; Phase 3 trial design to be presented at MDA – – Advancing four development candidates for the potential treatment of DMD amenable to skipping of exons 53, 45, 44, and 55 – – Year-end cash of $1.1 billion; reaffirming expected cash runway into Q1 2028 – WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) — Dyne...

~ Held Type A meeting with FDA to discuss AMT-130 for Huntington’s disease; Company evaluating Phase III development considerations and plans to request follow-up Type B meeting in the second quarter of 2026 ~ ~ Completed enrollment of the first cohort in the Phase I/IIa study of AMT-260 in refractory mesial temporal lobe epilepsy, with additional clinical data expected in the first half of 2026 ~ ~ Presented updated Phase I/II data from AMT-191 in Fabry disease showing durable, dose-dependent increases in α-Gal A enzyme activity ~ ~ Cash, cash equivalents and current investment securities of approximately $622.5 million as of December 31, 2025 expected to fund operations into the second half of 2029 ~ ~ uniQure to host earnings call at 8:00 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, March 02, 2026 (GLOBE NEWSWIRE) — uniQure N.V....

Continued strong financial results and cash generation, achieving all 2025 guidance metrics Full year earnings growth; GAAP EPS up 3%, Adjusted EPS up 19% Returned $791 million to shareholders through share repurchases and dividends Multi-year financial framework focused on growth in revenue, earnings, and cash flow BOCA RATON, Fla., March 02, 2026 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT), a leading provider of security, interactive, and smart home solutions serving residential and small business customers in the U.S., today reported results for the fourth quarter and full year of 2025. Financial highlights for the fourth quarter and full year are below with variances on a year-over-year basis unless otherwise noted. Results of the former commercial and solar businesses are presented as discontinued operations, except for cash...

MIAMI, March 02, 2026 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (together with NCL Corporation Ltd. (“NCLC”), “Norwegian Cruise Line Holdings”, “Norwegian”, “NCLH” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided guidance for the first quarter and full year 2026. HighlightsGrew total revenue 3.7% to $9.8 billion in 2025. GAAP net income was $423.2 million, with EPS of $0.92. Delivered Adjusted EBITDA1 of $2.73 billion in 2025, exceeding guidance, and representing an increase of 11% compared to 2024. Adjusted Net Income grew 15% to $1.045 billion. Adjusted EPS grew 19% to $2.11. Company sets full year 2026 guidance with Adjusted EPS expected to be $2.38. Company completed first phase of enhancements to Great Stirrup Cay, the...